Skip to content
Home
About
Who we are
Our Team
Distill EDC
Benefits
Features
Pricing
Industry News
Latest
RWE
Clinical Trials
Oncology
SVM
Case Studies
Publications
Endorsements
Pricing
Contact
×
Home
About
Who we are
Our Team
Distill EDC
Benefits
Features
Pricing
Industry News
Latest
RWE
Clinical Trials
Oncology
SVM
Case Studies
Publications
Endorsements
Pricing
Contact
PUBLICATIONS
Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors
09 February 2022
READ MORE
Posts navigation
← Retrospective analysis of real-world treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer starting first-line systemic therapy in the United Kingdom
A treatment evaluator tool to monitor the real-world effectiveness of inhaled aztreonam lysine in cystic fibrosis →